These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 16225927

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ocular and systemic side effects of brimonidine 0.2% eye drops (Alphagan) in children.
    Bowman RJ, Cope J, Nischal KK.
    Eye (Lond); 2004 Jan; 18(1):24-6. PubMed ID: 14707960
    [Abstract] [Full Text] [Related]

  • 5. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
    Bournias TE, Lai J.
    Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The safety and intraocular pressure-lowering efficacy of brimonidine tartrate 0.15% preserved with polyquaternium-1.
    Whitson JT, Ochsner KI, Moster MR, Sullivan EK, Andrew RM, Silver LH, Wells DT, James JE, Bosworth CF, Dickerson JE, Landry TA, Bergamini MV, Brimonidine 0.15% Study Group.
    Ophthalmology; 2006 Aug; 113(8):1333-9. PubMed ID: 16877072
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004%.
    Feldman RM, Tanna AP, Gross RL, Chuang AZ, Baker L, Reynolds A, Prager TC, Additivity Study Group.
    Ophthalmology; 2007 Jul; 114(7):1248-54. PubMed ID: 17509688
    [Abstract] [Full Text] [Related]

  • 10. Is brimonidine ophthalmic a safe therapy for infants?
    Daubert GP.
    J Clin Pharm Ther; 2006 Jun; 31(3):289-92. PubMed ID: 16789995
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of brimonidine in children with glaucoma.
    Enyedi LB, Freedman SF.
    J AAPOS; 2001 Oct; 5(5):281-4. PubMed ID: 11641636
    [Abstract] [Full Text] [Related]

  • 13. Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery.
    Chen TC.
    J Cataract Refract Surg; 2005 Sep; 31(9):1707-12. PubMed ID: 16246772
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy of brimonidine 0.2 per cent as adjunctive therapy to beta-blockers: a comparative study between POAG and CACG in Asian eyes.
    Ruangvaravate N, Kitnarong N, Metheetrairut A, Danwiriyakul W.
    J Med Assoc Thai; 2002 Aug; 85(8):894-900. PubMed ID: 12403210
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [The effect of brimonidine on postoperative hypertonia after an extracapsular cataract extraction].
    Katsimpris JM, Petropoulos IK, Voros G, Gerodimos G, Pharmakakis NM.
    J Fr Ophtalmol; 2003 Apr; 26(4):369-74. PubMed ID: 12843894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.